Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
18,067
Total Claims
$1.2M
Drug Cost
961
Beneficiaries
$1,229
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-1%
Opioid rate vs peers
2.2% vs 2.2% avg
-13%
Cost per patient vs peers
$1,229 vs $1,411 avg
-9%
Brand preference vs peers
9.6% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.2%
Opioid Rate
400
Opioid Claims
$14K
Opioid Cost
14.3%
Long-Acting Rate
Brand vs Generic
Brand: 1,722 claims · $877K
Generic: 16,136 claims · $292K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 414 | $285K |
| Insulin Glargine,hum.Rec.Anlog | 77 | $57K |
| Insulin Glargine,hum.Rec.Anlog | 70 | $44K |
| Sitagliptin Phosphate | 51 | $36K |
| Insulin Aspart | 65 | $32K |
| Insulin Degludec | 21 | $29K |
| Semaglutide | 20 | $28K |
| Rivaroxaban | 57 | $28K |
| Dapagliflozin Propanediol | 56 | $27K |
| Tiotropium Bromide | 31 | $21K |
| Budesonide/Formoterol Fumarate | 34 | $16K |
| Dulaglutide | 16 | $16K |
| Tirzepatide | 11 | $14K |
| Atorvastatin Calcium | 868 | $13K |
| Potassium Chloride | 406 | $12K |
Prescribing Profile
Patient Profile
76
Avg Age
47%
Female
1.12
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About